Skip to main content

Peer Review reports

From: Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells

Original Submission
11 Jun 2018 Submitted Original manuscript
12 Jul 2018 Author responded Author comments - Dandan Li
Resubmission - Version 2
12 Jul 2018 Submitted Manuscript version 2
23 Jul 2018 Editorially accepted
31 Jul 2018 Article published 10.1186/s12885-018-4690-1

You can find further information about peer review here.

Back to article page